These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38244275)

  • 1. Autologous intraarterial pancreatic bone-marrow mononuclear cells infusion in T2D patients: Changes on beta-cells function, insulin resistance, and inflammatory marker.
    Kurniawan F; Subekti I; Yunir E; Harbuwono DS; Purnamasari D; Tarigan TJE; Wisnu W; Tahapary DL; Wafa S; Astrella C; Christabel EV; Lubis AM; Wijaya IP; Karim B; Azizi MS; Suroyo I; Matondang S; Wicaksono KP; Wulandari D; Fasha I; Sartika CR; Irawan C; Soewondo P
    Curr Res Transl Med; 2024 Jun; 72(2):103437. PubMed ID: 38244275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical efficacy of autologous stem cell transplantation for the treatment of patients with type 2 diabetes mellitus: a meta-analysis.
    Wang ZX; Cao JX; Li D; Zhang XY; Liu JL; Li JL; Wang M; Liu Y; Xu BL; Wang HB
    Cytotherapy; 2015 Jul; 17(7):956-68. PubMed ID: 25824289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Autologous Bone Marrow-Derived Mesenchymal Stem Cell and Mononuclear Cell Transplantation in Type 2 Diabetes Mellitus: A Randomized, Placebo-Controlled Comparative Study.
    Bhansali S; Dutta P; Kumar V; Yadav MK; Jain A; Mudaliar S; Bhansali S; Sharma RR; Jha V; Marwaha N; Khandelwal N; Srinivasan A; Sachdeva N; Hawkins M; Bhansali A
    Stem Cells Dev; 2017 Apr; 26(7):471-481. PubMed ID: 28006991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous bone marrow mononuclear cell infusion and hyperbaric oxygen therapy in type 2 diabetes mellitus: an open-label, randomized controlled clinical trial.
    Wu Z; Cai J; Chen J; Huang L; Wu W; Luo F; Wu C; Liao L; Tan J
    Cytotherapy; 2014 Feb; 16(2):258-65. PubMed ID: 24290656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infusion of autologous bone marrow derived mononuclear stem cells potentially reduces urinary markers in diabetic nephropathy.
    Gaipov A; Taubaldiyeva Z; Askarov M; Turebekov Z; Kozina L; Myngbay A; Ulyanova O; Tuganbekova S
    J Nephrol; 2019 Feb; 32(1):65-73. PubMed ID: 30406605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of autologous bone marrow-derived stem cell transplantation in patients with type 2 diabetes mellitus.
    Bhansali A; Upreti V; Khandelwal N; Marwaha N; Gupta V; Sachdeva N; Sharma RR; Saluja K; Dutta P; Walia R; Minz R; Bhadada S; Das S; Ramakrishnan S
    Stem Cells Dev; 2009 Dec; 18(10):1407-16. PubMed ID: 19686048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long term effects of the implantation of autologous bone marrow mononuclear cells for type 2 diabetes mellitus.
    Hu J; Li C; Wang L; Zhang X; Zhang M; Gao H; Yu X; Wang F; Zhao W; Yan S; Wang Y
    Endocr J; 2012; 59(11):1031-9. PubMed ID: 22814142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous bone marrow mononuclear cell therapy improves symptoms in patients with end-stage peripheral arterial disease and reduces inflammation-associated parameters.
    Malyar NM; Radtke S; Malyar K; Arjumand J; Horn PA; Kröger K; Freisinger E; Reinecke H; Giebel B; Brock FE
    Cytotherapy; 2014 Sep; 16(9):1270-9. PubMed ID: 24972744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot study of autologous CD34-depleted bone marrow mononuclear cell transplantation via the hepatic artery in five patients with liver failure.
    Park CH; Bae SH; Kim HY; Kim JK; Jung ES; Chun HJ; Song MJ; Lee SE; Cho SG; Lee JW; Choi JY; Yoon SK; Han NI; Lee YS
    Cytotherapy; 2013 Dec; 15(12):1571-9. PubMed ID: 23849977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of atorvastatin on pancreatic Beta-cell function and insulin resistance in type 2 diabetes mellitus patients: a randomized pilot study.
    Goyal A; Singh S; Tandon N; Gupta N; Gupta YK
    Can J Diabetes; 2014 Dec; 38(6):466-72. PubMed ID: 24933106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous bone marrow-derived mononuclear cells transplantation in type 2 diabetes mellitus: effect on β-cell function and insulin sensitivity.
    Bhansali S; Dutta P; Yadav MK; Jain A; Mudaliar S; Hawkins M; Kurpad AV; Pahwa D; Yadav AK; Sharma RR; Jha V; Marwaha N; Bhansali S; Bhansali A
    Diabetol Metab Syndr; 2017; 9():50. PubMed ID: 28690682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of autologous bone marrow-derived stem cell transplantation in patients with type 2 diabetes mellitus: a randomized placebo-controlled study.
    Bhansali A; Asokumar P; Walia R; Bhansali S; Gupta V; Jain A; Sachdeva N; Sharma RR; Marwaha N; Khandelwal N
    Cell Transplant; 2014; 23(9):1075-85. PubMed ID: 23561959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fasting serum total bile acid levels are associated with insulin sensitivity, islet β-cell function and glucagon levels in response to glucose challenge in patients with type 2 diabetes.
    Wang XH; Xu F; Cheng M; Wang X; Zhang DM; Zhao LH; Cai HL; Huang HY; Chen T; Zhang XL; Wang XQ; Cheng XB; Su JB; Lu Y
    Endocr J; 2020 Nov; 67(11):1107-1117. PubMed ID: 32684527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-Arterial Injection of Autologous Bone Marrow-Derived Mononuclear Cells in Ischemic Stroke Patients.
    Hammadi AMA; Alhimyari F
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):239-241. PubMed ID: 30777565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin and C-peptide levels, pancreatic beta cell function, and insulin resistance across glucose tolerance status in Thais.
    Chailurkit LO; Jongjaroenprasert W; Chanprasertyothin S; Ongphiphadhanakul B
    J Clin Lab Anal; 2007; 21(2):85-90. PubMed ID: 17385686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma soluble leptin receptor levels are associated with pancreatic β-cell dysfunction in patients with type 2 diabetes.
    Morioka T; Emoto M; Yamazaki Y; Kurajoh M; Motoyama K; Mori K; Fukumoto S; Shioi A; Shoji T; Inaba M
    J Diabetes Investig; 2018 Jan; 9(1):55-62. PubMed ID: 28294581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous bone marrow stem cell transplantation for the treatment of type 2 diabetes mellitus.
    Wang L; Zhao S; Mao H; Zhou L; Wang ZJ; Wang HX
    Chin Med J (Engl); 2011 Nov; 124(22):3622-8. PubMed ID: 22340214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: rationale and design of the HEBE trial--a prospective, multicenter, randomized trial.
    Hirsch A; Nijveldt R; van der Vleuten PA; Biemond BJ; Doevendans PA; van Rossum AC; Tijssen JG; Zijlstra F; Piek JJ;
    Am Heart J; 2006 Sep; 152(3):434-41. PubMed ID: 16923409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting insulin resistance in type 2 diabetes via immune modulation of cord blood-derived multipotent stem cells (CB-SCs) in stem cell educator therapy: phase I/II clinical trial.
    Zhao Y; Jiang Z; Zhao T; Ye M; Hu C; Zhou H; Yin Z; Chen Y; Zhang Y; Wang S; Shen J; Thaker H; Jain S; Li Y; Diao Y; Chen Y; Sun X; Fisk MB; Li H
    BMC Med; 2013 Jul; 11():160. PubMed ID: 23837842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased serum betatrophin levels correlate with improved fasting plasma glucose and insulin secretion capacity after Roux-en-Y gastric bypass in obese Chinese patients with type 2 diabetes: a 1-year follow-up.
    Guo K; Yu H; Lu J; Bao Y; Chen H; Jia W
    Surg Obes Relat Dis; 2016 Aug; 12(7):1343-1348. PubMed ID: 27178609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.